Noticias de Eulerpool Marker Therapeutics

Marker Therapeutics Noticias de Acciones

Marker Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Marker Therapeutics.

• 11 de julio ·

  Yahoo
  Here's Why We're Watching Marker Therapeutics' (NASDAQ:MRKR) Cash Burn Situation
• 17 de junio ·

  Yahoo
  Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma
• 19 de diciembre ·

  Yahoo
  Marker Therapeutics Announces $16.1 Million Private Placement
• 19 de diciembre ·

  Yahoo
  Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
• 17 de diciembre ·

  Yahoo
  Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
• 10 de diciembre ·

  Yahoo
  Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium
• 6 de diciembre ·

  Yahoo
  Marker Therapeutics Leads 3 Noteworthy US Penny Stocks
• 26 de noviembre ·

  Yahoo
  Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit
• 17 de noviembre ·

  Yahoo
  Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations
• 23 de octubre ·

  Yahoo
  US Penny Stocks To Consider In October 2024